1 / 10

NVAC Influenza Working Group: Report and Recommendations

NVAC Influenza Working Group: Report and Recommendations. Charles Helms, M.D., Ph.D. October 5, 2004. NVAC Agenda - February, 2004. Influenza 2003-2004: Review and Lessons Learned for the Next Year and the Future The Current Season Vaccine Strain Selection Process and Regulatory Issues

nibal
Download Presentation

NVAC Influenza Working Group: Report and Recommendations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NVAC Influenza Working Group: Report and Recommendations Charles Helms, M.D., Ph.D. October 5, 2004

  2. NVAC Agenda - February, 2004 Influenza 2003-2004: Review and Lessons Learned for the Next Year and the Future • The Current Season • Vaccine Strain Selection Process and Regulatory Issues • Public Perceptions • Perspectives of Influenza Vaccine Manufacturers • Public Sector Roles in Adult and Childhood Influenza Vaccination • CMS • Company perspectives • Health Plans and Insurers • Vaccine Research – NIH • Pandemic Influenza Preparedness

  3. NVAC Influenza WG Purpose: Evaluate strategies and capabilities to reduce the impact of influenza disease in the US and make recommendations on how to substantially improve prevention and reduce disease burden.

  4. NVAC Influenza WG Subgroups • Influenza Vaccine Research, Development and Production: A. Arvin, Chair • Influenza Vaccine Delivery, Financing, and Demand: F. Guerra, Chair • Influenza Vaccine Recommendations and Strategies: J. Klein, Chair

  5. Efforts to Date • WG and SG conference calls: discussion and coordination • Influenza Summit (Atlanta) • Discussions with DHHS agencies, advisory committees, industry, health care providers, and others to review influenza vaccination program and offer recommendations • Preliminary report to NVAC on June 1 • SG reports drafted • Consensus WG report assembled and drafted from SG reports

  6. Today’s Steps • Presentation of consensus WG report • Input from Dr. Beato and NVAC

  7. Strengthening the Nation’s Influenza Vaccination System: An NVAC Assessment NVAC Influenza Working Group

  8. Strengthening the Nation’s Influenza Vaccination System: Recommendations • 1) Develop a system for ensuring delivery of influenza vaccine in all settings or “medical homes”. • 2) Work with payers to make influenza vaccine purchase less of a burden and financial risk for providers. • 3) Explore options for supporting a comprehensive vaccination program for adults. • 4) Consider expanded influenza vaccination recommendations.

  9. Strengthening the Nation’s Influenza Vaccination System:Recommendations (Cont’d) • 5) Better understand the burden of influenza illness in the United States. • 6) Implement new surveillance systems to better assess program impacts and measure vaccine effectiveness on an ongoing basis. • 7) Reinforce the importance of influenza vaccination for health care workers. • 8) Conduct a comprehensive review of the influenza research program and identify gaps and areas for additional support.

  10. Influenza Working Group • NVAC members: Drs. Arvin, Guerra, Klein, Schaffner, Davis • NVPO Staff: Drs. Gellin, Schwartz; Sarah Landry • Others: Norman Baylor, George Curlin, Dan Fishbein, Alison Mawle, Mark Messonier, Brian Murphy, Kari Sapsis, Lone Simonsen, Ray Strikas

More Related